Henning T. Mouridsen - Publications, H-index & Citations

Henning T. Mouridsen

herlev & gentofte hospital

66H指数

365论文数

2.1W被引数

收录论文 56

发表时间

The Prosigna 50-gene profile and responsiveness to adjuvant anthracycline-based chemotherapy in high-risk breast cancer patients

NPJ BREAST CANCER

IF7.6

2020-02-26

OAAI

Jensen, Maj-Britt; Laenkholm, Anne-Vibeke; Balslev, Eva; Buckingham, Wesley; Ferree, Sean; Glavicic, Vesna; Jensen, Jeanette Dupont; Knoop, Ann Soegaard; Mouridsen, Henning T.; Nielsen, Dorte; Nielsen, Torsten O.; Ejlertsen, Bent

Prognostic and predictive importance of the estrogen receptor coactivator AIB1 in a randomized trial comparing adjuvant letrozole and tamoxifen therapy in postmenopausal breast cancer: the Danish cohort of BIG 1-98

BREAST CANCER RESEARCH AND TREATMENT

IF3

2017-08-01

OAAI

Alkner, S.; Jensen, M. -B.; Rasmussen, B. B.; Bendahl, P. -O.; Ferno, M.; Ryden, L.; Mouridsen, H.

Danish Breast Cancer Cooperative Group 丹麦乳腺癌合作小组

clinical epidemiology

IF3.2

2016-10-01

OAAI

Christiansen, Peer; Ejlertsen, Bent; Jensen, Maj-Britt; Mouridsen, Henning

One year of adjuvant tamoxifen compared with chemotherapy and tamoxifen in postmenopausal patients with stage II breast cancer

EUROPEAN JOURNAL OF CANCER

IF7.1

2013-09-01

PREAI

Ejlertsen, Bent; Jensen, Maj-Britt; Elversang, Johanna; Rasmussen, Birgitte B.; Andersson, Michael; Andersen, Jorn; Nielsen, Dorte L.; Cold, Soren; Mouridsen, Henning T.

Prognostic and predictive role of ESR1 status for postmenopausal patients with endocrine-responsive early breast cancer in the Danish cohort of the BIG 1-98 trial

ANNALS OF ONCOLOGY

IF65.4

2012-05-01

OAAI

Ejlertsen, B.; Aldridge, J.; Nielsen, K. V.; Regan, M. M.; Henriksen, K. L.; Lykkesfeldt, A. E.; Muller, S.; Gelber, R. D.; Price, K. N.; Rasmussen, B. B.; Viale, G.; Mouridsen, H.

Lack of independent prognostic and predictive value of centromere 17 copy number changes in breast cancer patients with known HERZ and TOP2A status

MOLECULAR ONCOLOGY

IF4.5

2011-11-26

OAAI

Nielsen, Kirsten Vang; Ejlertsen, Bent; Moller, Susanne; Jensen, Maj-Britt; Balslev, Eva; Muller, Sven; Knoop, Ann; Mouridsen, Henning T.

Which patients benefit most from adjuvant aromatase inhibitors? Results using a composite measure of prognostic risk in the BIG 1-98 randomized trial

ANNALS OF ONCOLOGY

IF65.4

2011-10-01

OAAI

Viale, G.; Regan, M. M.; Dell'Orto, P.; Mastropasqua, M. G.; Maiorano, E.; Rasmussen, B. B.; MacGrogan, G.; Forbes, J. F.; Paridaens, R. J.; Colleoni, M.; Lang, I.; Thuerlimann, B.; Mouridsen, H.; Mauriac, L.; Gelber, R. D.; Price, K. N.; Goldhirsch, A.; Gusterson, B. A.; Coates, A. S.

Mortality Rates Among Early-Stage Hormone Receptor-Positive Breast Cancer Patients: A Population-Based Cohort Study in Denmark

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE

IF7.2

2011-08-31

OAAI

Christiansen, Peer; Bjerre, Karsten; Ejlertsen, Bent; Jensen, Maj-Britt; Rasmussen, Birgitte B.; Laenkholm, Anne-Vibeke; Kroman, Niels; Ewertz, Marianne; Offersen, Birgitte; Toftdahl, Dorte B.; Moller, Susanne; Mouridsen, Henning T.

Amplification of ESR1 may predict resistance to adjuvant tamoxifen in postmenopausal patients with hormone receptor positive breast cancer

BREAST CANCER RESEARCH AND TREATMENT

IF3

2010-06-17

OAAI

Nielsen, Kirsten Vang; Ejlertsen, Bent; Muller, Sven; Moller, Susanne; Rasmussen, Birgitte B.; Balslev, Eva; Laenkholm, Anne-Vibeke; Christiansen, Peer; Mouridsen, Henning T.

CEF is superior to CMF for tumours with TOP2A aberrations: a Subpopulation Treatment Effect Pattern Plot (STEPP) analysis on Danish Breast Cancer Cooperative Group Study 89D

BREAST CANCER RESEARCH AND TREATMENT

IF3

2010-05-13

OAAI

Gunnarsdottir, Katrin A.; Jensen, Maj-Britt; Zahrieh, David; Gelber, Richard D.; Knoop, Ann; Bonetti, Marco; Mouridsen, Henning; Ejlertsen, Bent

Cyclophosphamide, Methotrexate, and Fluorouracil; Oral Cyclophosphamide; Levamisole; or No Adjuvant Therapy for Patients With High-Risk, Premenopausal Breast Cancer

CANCER

IF5.1

2010-04-20

OAAI

Ejlertsen, Bent; Mouridsen, Henning T.; Jensen, Maj-Britt; Andersen, Jorn; Andersson, Michael; Kamby, Claus; Knoop, Ann S.

The risk of amenorrhoea after adjuvant chemotherapy for early stage breast cancer is related to inter-individual variations in chemotherapy-induced leukocyte nadir in young patients: Data from the randomised SBG 2000-1 study

EUROPEAN JOURNAL OF CANCER

IF7.1

2009-12-01

PREAI

Rosendahl, Mikkel; Ahlgren, Johan; Andersen, Jorn; Bergh, Jonas; Blomquist, Carl; Lidbrink, Elisabet; Lindman, Henrik; Mouridsen, Henning; Bjerre, Karsten; Andersson, Michael

Lack of TIMP-1 tumour cell immunoreactivity predicts effect of adjuvant anthracycline-based chemotherapy in patients (n=647) with primary breast cancer. A Danish Breast Cancer Cooperative Group Study

EUROPEAN JOURNAL OF CANCER

IF7.1

2009-09-01

PREAI

Willemoe, Gro L.; Hertel, Pernille B.; Bartels, Annette; Jensen, Maj-Britt; Balslev, Eva; Rasmussen, Birgitte B.; Mouridsen, Henning; Ejlertsen, Bent; Brunner, Nils

Bone fractures among postmenopausal patients with endocrine-responsive early breast cancer treated with 5 years of letrozole or tamoxifen in the BIG 1-98 trial

ANNALS OF ONCOLOGY

IF65.4

2009-09-01

139

OAAI

Rabaglio, M.; Sun, Z.; Price, K. N.; Castiglione-Gertsch, M.; Hawle, H.; Thurlimann, B.; Mouridsen, H.; Campone, M.; Forbes, J. F.; Paridaens, R. J.; Colleoni, M.; Pienkowski, T.; Nogaret, J. -M.; Lang, I.; Smith, I.; Gelber, R. D.; Goldhirsch, A.; Coates, A. S.

Association between tumor tissue TIMP-1 levels and objective response to first-line chemotherapy in metastatic breast cancer

BREAST CANCER RESEARCH AND TREATMENT

IF3

2009-08-04

OAAI

Klintman, Marie; Wurtz, Sidse Ornbjerg; Christensen, Ib Jarle; Hertel, Pernille Braemer; Ferno, Marten; Malmberg, Martin; Mouridsen, Henning; Cold, Frederik; Schrohl, Anne-Sofie; Foekens, John A.; Malmstrom, Per; Brunner, Nils

In situ aromatase expression in primary tumor is associated with estrogen receptor expression but is not predictive of response to endocrine therapy in advanced breast cancer

BMC CANCER

IF3.4

2009-06-16

OAAI

Lykkesfeldt, Anne E.; Henriksen, Katrine L.; Rasmussen, Birgitte B.; Sasano, Hironobu; Evans, Dean B.; Moller, Susanne; Ejlertsen, Bent; Mouridsen, Henning T.

Population-Based Study of Peritumoral Lymphovascular Invasion and Outcome Among Patients With Operable Breast Cancer

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE

IF7.2

2009-05-20

OAAI

Ejlertsen, Bent; Jensen, Maj-Britt; Rank, Fritz; Rasmussen, Birgitte B.; Christiansen, Peer; Kroman, Niels; Kvistgaard, Marianne E.; Overgaard, Marie; Toftdahl, Dorte B.; Mouridsen, Henning T.

Adjuvant chemotherapy in breast cancer patients induces temporary salivary gland hypofunction

ORAL ONCOLOGY

IF3.9

2008-02-01

PREAI

Jensen, Siri Beier; Mouridsen, Henning T.; Reibel, Jesper; Bruenner, Nits; Nauntofte, Birgitte

Prognostic effect of estrogen receptor status across age in primary breast cancer

INTERNATIONAL JOURNAL OF CANCER

IF4.7

2007-12-24

150

OAAI

Bentzon, Niels; Duering, Maria; Rasmussen, Birgitte Bruun; Mouridsen, Henning; Kroman, Niels

Predictors of early relapse in postmenopausal women with hormone receptor-positive breast cancer in the BIG 1-98 trial

ANNALS OF ONCOLOGY

IF65.4

2007-05-01

112

OAAI

Mauriac, L.; Keshaviah, A.; Debled, M.; Mouridsen, H.; Forbes, J. F.; Thuerlimann, B.; Paridaens, R.; Monnier, A.; Lang, I.; Wardley, A.; Nogaret, J.-M.; Gelber, R. D.; Castiglione-Gertsch, M.; Price, K. N.; Coates, A. S.; Smith, I.; Viale, G.; Rabaglio, M.; Zabaznyi, N.; Goldhirsch, A.

研究方向